How did Maxcyte's revenue and expenses trend in Q4 2024?

Maxcyte's revenue and expenses in Q4 2024 showed a decline in revenue and an increase in expenses, resulting in a negative net income.

1. Revenue Trend: Maxcyte's revenue for Q4 2024 was $21.09 million, $16.41 million, $15.29 million, $13.77 million, $1.13 million, and $868,000 for different business segments. The highest revenue was from product sales, but the overall trend showed a decrease in revenue compared to previous quarters.
2. Expense Trend: The company's operating expenses were $4.61 million, and it had R&D expenses and selling, general, and administrative expenses amounting to $14.7 million. These expenses were consistent across different business segments, indicating a fixed cost structure.
3. Net Income: The net income for Q4 2024 was -$10.6 million, which suggests that the company had a significant loss in the quarter. This loss can be attributed to the decline in revenue and the high expenses, particularly the selling, general, and administrative expenses.

1/4

MXCT Revenue By Business